Education
About Us
Working with TipRanks
Follow Us
GKAT - ETF AI Analysis
Top Page
Scharf Global Opportunity ETF (GKAT)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key positions, such as Franco-Nevada and McKesson, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Health Care, Financials, and Technology, reducing reliance on any single industry.
Steady Asset Growth
The fund has a healthy level of assets under management, indicating investor confidence and stability.
Negative Factors
High Geographic Concentration
With over 87% of its exposure in U.S. companies, the ETF lacks significant diversification across global markets.
Underperforming Holdings
Some top holdings, such as Fiserv and Haleon, have lagged in performance, potentially dragging on overall returns.
Moderate Expense Ratio
The ETF's expense ratio is higher than some low-cost alternatives, which could eat into long-term returns.
GKAT vs. SPDR S&P 500 ETF (SPY)
AUM131.08M
RegionGlobal
Expense Ratio0.59%
Beta0.67
IssuerScharf
Inception DateAug 25, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume498
30 Day Avg. Volume2,676
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
44.83Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering36
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GKAT Summary
The Scharf Global Opportunity ETF (GKAT) is an actively managed fund designed to invest in companies worldwide, aiming for long-term growth. It focuses on the total market and includes a mix of sectors like healthcare, financials, and technology. Some well-known companies it holds are Microsoft and McKesson. This ETF might appeal to investors looking for global diversification and a carefully selected portfolio of high-potential stocks. However, since it invests heavily in U.S. companies and specific sectors like healthcare, its performance can be impacted by changes in those areas or broader market trends.
How much will it cost me?The Scharf Global Opportunity ETF (GKAT) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because it’s actively managed, requiring more research and analysis compared to passively managed funds that track an index.
What would affect this ETF?The Scharf Global Opportunity ETF (GKAT) could benefit from growth in the healthcare and technology sectors, which make up a significant portion of its holdings, as well as global economic recovery driving demand for industrial and financial services. However, rising interest rates or regulatory changes could negatively impact financial and technology stocks, while geopolitical tensions or slowing global growth might affect its broad geographic exposure. The fund's focus on high-conviction investments also introduces risks if key holdings underperform.
GKAT Top 10 Holdings
The Scharf Global Opportunity ETF (GKAT) leans heavily on health care and financials, with McKesson and Chubb providing a steady lift thanks to strong earnings and bullish momentum. Franco-Nevada, a standout in the materials sector, is also rising on solid profitability and strategic acquisitions. However, energy exposure through Occidental Petroleum is dragging the fund, as bearish trends and declining metrics weigh on performance. Zoetis, another health care name, is lagging due to bearish momentum despite its solid fundamentals. With its global focus, GKAT offers a diverse mix but remains concentrated in a few high-conviction sectors.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Brookfield Corporation | 6.47% | $8.34M | $115.38B | 13.88% | 66 Neutral | |
| Franco-Nevada | 4.84% | $6.24M | $40.02B | 68.64% | 74 Outperform | |
| Zoetis | 4.17% | $5.38M | $56.27B | -27.75% | 70 Outperform | |
| Union Pacific | 4.11% | $5.30M | $136.82B | -5.94% | 66 Neutral | |
| McKesson | 4.08% | $5.26M | $109.07B | 41.08% | 72 Outperform | |
| Occidental Petroleum | 4.06% | $5.23M | $40.81B | -17.69% | 67 Neutral | |
| Heineken | 3.74% | $4.82M | $45.28B | 7.85% | 78 Outperform | |
| Novartis | 3.63% | $4.68M | $249.67B | 24.38% | 80 Outperform | |
| Chubb | 3.27% | $4.22M | $117.24B | 2.60% | 80 Outperform | |
| Haleon PLC Sponsored ADR | 3.27% | $4.21M | $43.78B | 2.40% | 67 Neutral |
GKAT Technical Analysis
Positive
―
Price Trends
39.72
Positive
Market Momentum
-0.10
Negative
58.00
Neutral
82.38
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GKAT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.24, equal to the 50-day MA of 39.72, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.10 indicates Negative momentum. The RSI at 58.00 is Neutral, neither overbought nor oversold. The STOCH value of 82.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GKAT.
GKAT Peer Comparison
Comparison Results
Performance Comparison
GKAT
Scharf Global Opportunity ETF
40.00
1.37
3.55%
RGEF
Rockefeller Global Equity ETF
―
―
―
KAT
Scharf ETF
―
―
―
DWLD
Davis Select Worldwide Etf
―
―
―
NANC
Unusual Whales Subversive Democratic Trading ETF
―
―
―
FMAG
Fidelity Magellan ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents